NCT06282575 2026-03-24
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Jazz Pharmaceuticals
Phase 3 Recruiting
Jazz Pharmaceuticals
AstraZeneca
City of Hope Medical Center
First Affiliated Hospital of Zhejiang University
Tata Memorial Centre